GL1X · GenesisL1 explorer

MolNFT v1 · #66963 · protein

Plasmodium falciparum dihydroorotate dehydrogenase bound with triazolopyrimidine-based inhibitor DSM2

3I68 · Dihydroorotate dehydrogenase homolog, mitochondrial: “Plasmodium falciparum dihydroorotate dehydrogenase bound with triazolopyrimidine-based inhibitor DSM2”. X-ray diffraction, 3 ligands (J4Z, FMN, ORO), 3 pockets (best druggability…

PDB
3I68
Type
protein
Length
378 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydroorotate dehydrogenase homolog, mitochondrial
EC
1.3.3.1
UniProt
Q08210
Ligands
J4Z, FMN, ORO
Pockets
3 · best druggability 0.85

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydroorotate dehydrogenase homolog, mitochondrial (EC 1.3.3.1)protein37843% helix, 16% strandQ08210

Ligands and binding sites

  • J4Z · N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine · ligand · chains A
  • FMN · Flavin mononucleotide · ligand · chains A
  • ORO · Orotic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14240.850.9266J4Z, FMN, ORO
2640.360.7820empty
3540.350.7917empty

Compared structures

  • 3I68 · Plasmodium falciparum dihydroorotate dehydrogenase bound with triazolopyrimidine-based… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q08210 · AlphaFold monomer V2.0 prediction for dihydroorotate dehydrogenase (quinone)… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.